Sponsor:
GB002, Inc.
Code:
NCT05934526
Conditions
Pulmonary Arterial Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
Seralutinib
Generic Dry Powder Inhaler
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations